COR-ART, NCT01691313: Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm |
|
|
| Completed | 2 | 104 | RoW | Vanoxerine, GBR12909, Placebo, Placebo to match vanoxerine | Laguna Pharmaceuticals, Inc. | Symptomatic Atrial Fibrillation, Atrial Flutter | 09/13 | 10/13 | | |
